Skip to main content
. 2008 Dec 20;20(8):1429–1437. doi: 10.1007/s00198-008-0816-7

Fig. 2.

Fig. 2

Kaplan–Meier estimates of the effect of daily oral 1 mg minodronate for 24 months on the risk of vertebral fractures in osteoporotic subjects. Cumulative incidence of vertebral fractures from the start of the study. Minodronate treatment reduced relative risk of vertebral fractures by 59%